Ankündigung Erscheint vsl. September 2020 Abbildung von Kihara | Druggable Lipid Signaling Pathways | 1. Auflage | 2020 | 1274 |


Druggable Lipid Signaling Pathways

Jetzt vorbestellen! Wir liefern bei Erscheinen (Erscheint vsl. September 2020)

Buch. Hardcover

1st ed. 2020. 2020

vi, 260 S. 12 s/w-Abbildungen, 21 Farbabbildungen, 33 Farbtabellen, Bibliographien

In englischer Sprache

Springer. ISBN 978-3-030-50620-9

Format (B x L): 17,8 x 25,4 cm


This edited work presents a series of reviews focusing on Druggable Lipid Signaling Pathways. It enables researchers in both academic institutions and industry as well as physicians to understand historical aspects of lipid signaling and future directions of drug discovery targeting lipid signaling pathways. This book provides 9 pathways including acyltransferases, prostanoids, leukotrienes, epoxy fatty acids, sphingolipids, lysophospholipids, endocannabinoids, phosphoinositides, and lipid GPCRs. Readers will discover the importance of each lipid signaling pathway that contributes to broad range of diseases including neurological and neuropsychiatric diseases, pain, metabolic syndromes, cardiovascular diseases, cancer, dermatological diseases, fibrosis, inflammation, etc. Also, readers will recognize that many drugs targeting lipid signaling have been clinically used. Drugs currently under development are also discussed in each chapter, which includes some information about clinical trials and strategic drug designs.

Top-Produkte dieser Kategorie


  • Rezensionen

    Dieses Set enthält folgende Produkte:
      Auch in folgendem Set erhältlich:
      • nach oben

        Ihre Daten werden geladen ...